HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akito Hattori Selected Research

Therapeutics

1/2021Case Report: Durvalumab-Associated Encephalitis in Extensive-Stage Small Cell Lung Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akito Hattori Research Topics

Disease

1Neuroblastoma
01/2022
1Obesity
01/2022
1Inflammation (Inflammations)
01/2022
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2021
1Anorexia
01/2021
1Encephalitis (Encephalitis, Rasmussen)
01/2021
1Fever (Fevers)
01/2021
1Autoimmune Diseases of the Nervous System
01/2021
1Phototoxic Dermatitis (Phototoxicity)
12/2013

Drug/Important Bio-Agent (IBA)

1Proteins (Proteins, Gene)FDA Link
01/2022
1GlycolipidsIBA
01/2022
1CytokinesIBA
01/2022
1Transferrin (beta 2 Transferrin)IBA
01/2022
1SteroidsIBA
01/2021
1Carboplatin (JM8)FDA LinkGeneric
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Etoposide (VP 16)FDA LinkGeneric
01/2021
1durvalumabIBA
01/2021
1Coloring Agents (Dyes)IBA
12/2013

Therapy/Procedure

1Therapeutics
01/2021
1Immunotherapy
01/2021